PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-8.41%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-20.38%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-5.78%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
2.88%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
-4.03%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.89%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-20.02%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-4.60%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
8.02%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
23.41%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
15.28%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
25.87%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
50.40%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
18.39%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
29.26%
Similar pre-tax margin growth to CRWV's 26.86%. Walter Schloss would investigate industry trends.
9.30%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
22.98%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
34.28%
Net margin growth 1.25-1.5x CRWV's 25.27%. Bruce Berkowitz would examine sustainability.
25.00%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
25.00%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
-2.55%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-2.27%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.